COVID Olfactory Trial Hints at Possible Benefit
4.7 (674) · € 6.99 · En stock
Small sample size limits significance of findings
Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis
How a simple smell test could curb COVID-19 and help reopen the economy, CU Boulder Today
Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms: Trends in Neurosciences
MASH-COVID Trial Hints at Role for Targeting GM-CSF in Hyperinflammatory COVID-19
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial, BMC Medicine
COVID-19 - Wikipedia
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study - The Lancet Psychiatry
Frontiers COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection
Mixed results for nasal theophylline to treat COVID-related loss of smell
Pathogens, Free Full-Text
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments
Post-viral effects of COVID-19 in the olfactory system and their implications - The Lancet Neurology
:format(jpg)/f.elconfidencial.com%2Foriginal%2Fd45%2F11a%2F2ff%2Fd4511a2ff6abfbd453a1d4861c048858.jpg)
